Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alcobra Ltd (NASDAQ:ADHD)

1.14
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
0.83
Today|||52-Week Range
5.75
-45.71%
Year-to-Date
No recent news for Alcobra Ltd.

Today’s Trading

Previous close1.14
Today’s open1.14
Day’s range1.13 - 1.16
Volume214,305
Average volume (3 months)732,229
Market cap$31.4M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+1.11%
Earnings growth (this year)+30.34%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
XBIOXenetic Biosciences ...+0.14+3.67%
INNLInnocoll Holdings PL...-0.01-1.06%
DFFNDiffusion Pharmaceut...-0.16-5.37%
MRNSMarinus Pharmaceutic...+0.01+0.66%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 17, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$24.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Yaron Daniely
Chief Operating Officer &
Chief Financial Officer
Tomer Berkovitz
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts


Search for Jobs